ATM gene deletion in patients with adult acute lymphoblastic leukemia

Cancer

Volumn 88, Issue 5, 2000, Pages 1057-1062

  Haidar, Mohammad A ^a   Kantarjian, Hagop ^a   Manshouri, Taghi ^a   Chang, Chin Yung ^a   O'Brien, Susan ^a   Freireich, Emil ^a   Keating, Michael ^a   Albitar, Maher ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Acute lymphoblastic leukemia; Ataxia telangiectasia; ATM; Microsatellite; Radioimmunoassay; Survival

Indexed keywords

CELL DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; ATAXIA TELANGIECTASIA; CHROMOSOME 11Q; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE DELETION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEFICIENCY; SURVIVAL;

ADULT; ATAXIA TELANGIECTASIA; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 11; DNA-BINDING PROTEINS; ELECTROPHORESIS; FEMALE; GENE DELETION; HETEROZYGOTE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; RADIOIMMUNOASSAY; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS;

EID: 0034162650     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000301)88:5<1057::AID-CNCR16>3.0.CO;2-6     Document Type: Article

References (29)

1. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase, Science 1995;268:1749-53.
2. Gilad S, Chessa L, Khosravi R, Russell P, Galanty Y, Piane M, et al. Genotype-phenotype relationship in ataxia-telangiectasia and variants Am J Hum Genet 1998;62:551-61.
3. Stankovic T, Kidd AMJ, Sutcliffe A, McGuire GM, Robinson P, Weber P, et al. ATM mutations and phenotypes in ataxiatelangiectasia families in the British isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 1998;62:334-45.
4. Taylor AMR, Metcalfe JA, Thick J, Mak Y-F. Leukemia and lymphoma in ataxia telangiectasia. Blood 1996;87:423-38.
5. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Shiloh Y, et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 1995;4:2025-32.
6. Westphal CH, Schmaltz C, Rowan S, Elson A, Fisher DE, Leder P. Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res 1997;57:1664-67.
7. Hawley RS, Friend SH. Strange bedfellows in even stranger places: the role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to p53. Genes Dev 1996;10: 2383-8.
8. Starostik P, Manshouri T, O'Brien S, Freireich E, Kantarjian H, Haidar M, et al. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res 1998;58:4552-7.
9. Bullrich F, Debora S, Kitada S, Starostile P, Kipps T, Keating M, et al. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 1999;59:24-7.
10. Vorechovsk'y I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, et al. Clustering of missense mutation in the ataxia -telangiectasia gene in sporadic T-cell leukemia. Nat Genet 1997;17:96-9.
11. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, et al. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 1997;3:1155-9.
12. Yuille MAR, Coignet LJA, Abraham SM, Yaqub F, Luo L, Matutes E, et al. ATM is usually rearranged in T-cell prolymphocytic leukaemia. Oncogene 1998;16:789-96.
13. Strout MP, Caligiuri MA. Developments in cytogenetics and oncogenes in acute leukemia. Curr Opin Oncol 1997;9:8-17.
14. Federl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 1998;91:3995-4019.
15. Srinivas T, Aplan PD. Molecular biology of acute lymphocytic leukemia. Semin Oncol 1997;24:45-56.
16. Joh T, Kagami Y, Yamamoto K, Segawa T, Takizawa J, Takahashi T, et al. Identification of MLL and chimeric MLL gene products involved in 11q23 translocation and possible mechanisms of leukemogenesis by MLL truncation. Oncogene 1996;13:1945-53.
17. Tkachuk DC, Kohler S, Cleary ML. Involvement of a homology of Drosophila trithorax by 11q23 translocations in acute leukemias. Cell 1992;71:691-700.
18. Pabst T, Schwaller J, Bellomo MJ, Oestreicher M, Muhlematter D, Tichelli A, et al. Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias. Blood 1996; 88:1026-34.
19. Takeuchi S, Bartram CR, Wada M, Reiter A, Hatta Y, Seriu T, et al. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res 1995;55:5377-82.
20. Reato G, Basso G, Putti MC, Cignetti A, Guarini A, Foa R. Microsatellite analysis in childhood acute lymphoblastic leukemia. Hematologica 1998;83:403-7.
21. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev 1996;10: 2411-22.
22. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomary CA Jr., Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992;356:215-21.
23. Barlow C, Brown KD, Deng CX, Tagle DA, Wynshaw-Boris A. ATM selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat Genet 1997;17:453-6.
24. Canman CE, Lim D-S, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998;281:1677-9.
25. Cortes JE, Kantarjian HM. Acute lymphoblastic leukemia: a comprehensive review with emphasis on biology and therapy. Cancer 1995;76:2393-417.
26. Cortes JE, Kantarjian H, Freireich EJ. Acute lymphocytic leukemia: a comprehensive review with emphasis on biology and therapy. Cancer Treat Res 1996;84:291-323.
27. Herzog K-H, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 1998;280:1089-91.
28. Zwiebel JA, Cheson BD. Chronic lymphocytic leukemia: staging and prognostic factors. Semin Oncol 1998;25:42-59.
29. Adkins JC, Peters DH, Markham A. Fludarabine. An update of its pharmacology and use in the treatment of hematological malignancies. Drugs 1997;53:105-37.